ArticleCurrent oncology (Toronto, Ont.)2012
Medullary thyroid cancer and pseudocirrhosis: case report and literature review.
Article in Current oncology (Toronto, Ont.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- Pseudocirrhosis and portal hypertension in patients with metastatic cancers: a systematic review and meta-analysis.Scientific reports · 2022Pooled it
- Pseudocirrhosis due to liver metastasis from lung squamous cell carcinoma: A case report.Oncology letters · 2026Article
- Article
- Pseudocirrhosis: A Case Series with Clinical and Radiographic Correlation and Review of the Literature.Digestive diseases and sciences · 2024Review
- Chemotherapy-associated liver morphological changes in hepatic metastases (CALMCHeM).Diagnostic and interventional radiology (Ankara, Turkey) · 2023Article
- Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices.The oncologist · 2022Article
- Liver metastases - An unusual cause of portal hypertension: A case report.Annals of medicine and surgery (2012) · 2022Article
- Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.Molecular and clinical oncology · 2022Article
- Pseudocirrhosis caused by lung adenocarcinoma with diffuse liver metastasis: An autopsy case report.Thoracic cancer · 2021Article
- Pseudocirrhosis in Breast Cancer - Experience From an Academic Cancer Center.Frontiers in oncology · 2021Article
- Recurrent metastatic breast cancer presenting with portal hypertension and pseudocirrhosis.BMJ case reports · 2019Article
- Clinical features of pseudocirrhosis in metastatic breast cancer.Breast cancer research and treatment · 2019Article
- Pseudocirrhosis caused by regorafenib in an advanced rectal cancer patient with multiple liver metastases.Molecular and clinical oncology · 2017Article
- Pseudocirrhosis of breast cancer metastases to the liver treated by chemotherapy.Cancer research and treatment · 2014Article
- Pseudocirrhosis as a complication after chemotherapy for hepatic metastasis from breast cancer.Clinical and molecular hepatology · 2013Article
- Pseudocirrhosis: A Case Series and Literature Review.Case reports in gastroenterologyArticle
- Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
Pseudocirrhosis is a rare form of liver disease that can cause clinical symptoms and radiographic signs of cirrhosis; however, its histologic features suggest a distinct pathologic process. In the setting of cancer, hepatic metastases and systemic chemotherapy are suspected causes of pseudocirrhosis. Here, we present a patient with medullary thyroid carcinoma metastatic to the liver who developed pseudocirrhosis while on maintenance sunitinib after receiving 5-fluorouracil, leucovorin, and oxaliplatin (folfox) in combination with sunitinib. Cirrhotic change in liver morphology was accompanied by diffusely infiltrative carcinomatous disease resembling the primary tumor. We discuss the diagnosis of pseudocirrhosis in this case and review the literature regarding pseudocirrhosis in cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.